MRI-Based Assessment of Safe Margins in Tumor Surgery

Laura Bellanova1, Thomas Schubert1, Olivier Cartiaux1

  • 1Computer Assisted and Robotic Surgery (CARS), Institut de Recherche Expérimentale et Clinique (IREC), Université catholique de Louvain Tour Pasteur +4, Avenue Mounier, 53, 1200 Brussels, Belgium.

Sarcoma
|April 5, 2014
PubMed

Insights

Magnetic Resonance Imaging (MRI) can accurately assess tumor resection margins in excised specimens, matching traditional histopathology. This feasibility study in rats shows MRI

Area of Science:

  • Surgical Oncology
  • Medical Imaging
  • Experimental Pathology

Background:

  • Histological analysis of excised tumor specimens is the standard for assessing surgical resection margin safety.
  • Accurate margin assessment is critical to prevent cancer recurrence.

Purpose of the Study:

  • To evaluate the feasibility of using Magnetic Resonance Imaging (MRI) to assess resection margins in freshly explanted rat tumor specimens.
  • To compare MRI-based margin assessment with conventional histopathological analysis.

Main Methods:

  • Fourteen rat sarcoma specimens were resected and analyzed using both MRI and histology.
  • Specimen slicing was standardized, and corresponding slices were paired for analysis.
  • 498 margins were measured and classified using the Union for International Cancer Control (UICC) criteria (R0, R1, R2).

Main Results:

  • The mean difference in margin measurement between MRI and histology was 0.3 mm (SD 1.0 mm).
  • The agreement interval between the two methods was [-1.7 mm; 2.2 mm].
  • A strong correlation (κ = 0.84, P < 0.05) was found between MRI and histology for UICC margin classification.

Conclusions:

  • MRI is a feasible tool for assessing resection margins in excised tumor specimens.
  • MRI demonstrates comparable accuracy to histopathological analysis for margin assessment.
  • Integrating MRI into surgical workflow may enhance intraoperative decision-making and guide histopathological analysis.